Achieve Life Sciences, Inc. (ACHV) Financials

ACHV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 33.1 million 22.4 million
Dec. 31, 2025 41.8 million 20.3 million
Sept. 30, 2025 52.0 million 18.4 million
June 30, 2025 58.9 million 17.3 million

ACHV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.9 million -685000
Dec. 31, 2025 -18.0 million 1.3 million
Sept. 30, 2025 -11.3 million 2.3 million
June 30, 2025 -9.1 million 2.9 million

ACHV Net Income

No data available :(

ACHV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 29.3 million 9.3 million 51000
Dec. 31, 2025 36.4 million 11.2 million 66000
Sept. 30, 2025 48.1 million 8.7 million 21000
June 30, 2025 55.4 million 8.7 million 95000

ACHV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 53.4 million
Dec. 31, 2025 53.3 million
Sept. 30, 2025 51.0 million
June 30, 2025 34.7 million

ACHV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 3.3 million 7.1 million 24000
Dec. 31, 2025 3000 3.9 million 10.9 million -
Sept. 30, 2025 - 5.3 million 9.4 million -
June 30, 2025 - 6.7 million 5.9 million -

ACHV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 57000
Dec. 31, 2025 - 57000
Sept. 30, 2025 - 54000
June 30, 2025 - 55000

ACHV

Price: $5.56

52 week price:
2.00
6.15

Earnings Per Share: -1.07 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 92500

Ebitda: -8.6 million

Market Capitalization: 543.1 million

Links: